Workflow
X @Bloomberg
AbbVieAbbVie(US:ABBV) Bloomberg·2025-08-25 14:40

AbbVie agreed to buy an experimental depression treatment from Gilgamesh Pharmaceuticals Inc. for up to $1.2 billion in a deal that highlights the drug industry’s growing interest in next-generation psychedelic compounds https://t.co/Oy0JoiRLZh ...